Brief: Kiniksa Pharmaceuticals Q1 EPS USD -0.18
02/05/2023 12:36
May 2 (Reuters) - Kiniksa Pharmaceuticals Q1 EPS USD -0.18. * Q1 pretax profit USD -9.364 million * Q1 operating expenses USD 59.541 million * Q1 net income USD -12.27 million * Q1 product revenue USD 42.659 million
Recent news on Kiniksa Pharmaceuticals International
See all newsKiniksa Pharmaceuticals International, PLC reports results for the quarter ended June 30 - Earnings Summary
Kiniksa Pharmaceuticals Q2 product revenue rises on ARCALYST sales
Kiniksa Pharmaceuticals International, PLC expected to post earnings of 30 cents a share - Earnings Preview
Cardiovascular drugmaker Kiniksa's Q1 net income rises
Kiniksa Q4 revenue rises on ARCALYST sales